Medindia
Advertisement

Advances in the Study of Cognitive Enhancers in Schizophrenia

by Ramya Rachamanti on January 16, 2019 at 11:19 AM

Advances in the Study of Cognitive Enhancers in Schizophrenia
Schizophrenia, a serious chronic mental disorder involving a series of symptoms, is one of the leading causes of disability worldwide. Symptoms of this disorder like delusions and hallucinations could be adequately treated by antipsychotics.

Yet patients experience many difficulties on a social and functional level, in other words, "they have severe problems in carrying out everyday life activities ranging from personal hygiene or managing their finances to maintaining a stable social network, having a partner or holding down a job. And there is no treatment for this", explained Arantzazu Zabala, a Doctor in Psychology specialising in neuropsychology.
Advertisement


Since the year 2000, explained Zabala, one of the authors of the work, "it has emerged that it is the cognitive impairments that correlate most with functional deficits, and since then, to combat these deficits, the scientific community has been developing a broad range of interventions, including cognitive enhancers. These are drugs which when added to the routine, antipsychotic treatment, could reverse or, to a certain extent, reduce the cognitive impairments displayed by patients".

Methodological improvements in the interests of progress

Nine clinical trials from across the world were analysed in a study conducted by researchers from the UPV/EHU, the University of La Rioja, the BioCruces Health Research Institute and Cibersam (Centre for Biomedical Research into Mental Health).
Advertisement

The trials involved patients with schizophrenia and used three acetylcholinesterase inhibitors (donepezil, galantamine and rivastigmine)that are very effective in improving the cognitive impairments of patients with Alzheimer's.

As the researcher explained, "right now there is insufficient evidence to be able to recommend acetylcholinesterase inhibitors as a cognitive enhancer for patients with schizophrenia". In fact, numerous limitations in the nine trials studied have emerged in this meta-analysis, and various improvements that need to be applied to studies of this type have been proposed.

Doctor Zabala is nevertheless optimistic: "Much work remains to be done, but it's heading in the right direction." The researcher insists that the trials analysed "are original pieces of work, are among the first ones, but right now the therapeutic targets have expanded greatly. Our work draws attention to the need for studies that will offer sufficient methodological quality to be able to guarantee the effectiveness of the compounds".

In this respect, the research conducted at the UPV/EHU proposes a series of improvements in studies of this type, which the scientific community should bear in mind "so that in addition to demonstrating the effectiveness of a drug on the patient's functionality, aspects such as the safety and tolerance of it are also studied," concluded Zabala.



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Stroop Effect
Plant-Based Diet may Reduce the Risk of COVID-19
Lower Respiratory Tract Infections Linked to Obstructive Sleep Apnea in Children
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Schizophrenia Mental Health - Neurosis vs Psychosis Smart Drugs Schizoaffective Disorder Mind-wandering Paranoia Anosognosia Antipsychotic Medications 

Recommended Reading
Schizophrenia
Schizophrenia is a mental disorder characterized by symptoms of thought, behavior and social ......
Anosognosia
Anosognosia is the lack of awareness or insight in a patient to understand that he/she has a disease...
Antipsychotic Medications
Antipsychotics are the class of drugs which help in treating mental disorders like schizophrenia, bi...
Mental Health - Neurosis vs Psychosis
Mental well-being is a concern and abnormal coping of emotions can lead to neurosis or psychosis. Me...
Mind-wandering
Mind wandering is a spontaneous and unintentional shifting of attention of thoughts from a primary t...
Paranoia
Paranoia is a false belief where the individual feels unfairly targeted or persecuted by everyone el...
Schizoaffective Disorder
Schizoaffective disorder is a serious mental disorder in which the individual reflects symptoms that...
Smart Drugs
Nootropics are drugs or substances which improve cognition that are being increasingly used nowadays...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use